EVIDENCE LIBRARY
Taiwan Dementia Claims Study Found Frequent Benzodiazepine–Herbal Formula Co-Prescribing
A historical claims study described concurrent prescribing patterns. It did not test whether particular combinations were effective, safe, or responsible for cognitive changes.
A historical claims study described concurrent prescribing patterns. It did not test whether particular combinations were effective, safe, or responsible for cognitive changes.
The prescribing network
Among newly diagnosed dementia patients, the researchers identified a subgroup receiving prescribed Chinese herbal formulas for mental or neurologic conditions. Common formula patterns differed across time after diagnosis.
Benzodiazepines were the most common sedative drugs combined with the formulas. Network diagrams summarized recurring prescription pairs rather than measured pharmacologic interactions.
What co-prescribing leaves open
Records did not capture all products bought without a physician’s prescription. They also lacked prospective cognitive outcome measurements, so later time since diagnosis could not be treated as a direct severity scale.
A prescription overlap does not establish actual simultaneous ingestion, benefit, or an adverse interaction. The paper supports asking specifically about both prescribed and nonprescribed products. In an individual case, obtain the ingredients, dose, administration dates, and observed function before attributing a change to a benzodiazepine–herb combination. Frequent historical use is not proof of safe compatibility.
Source paper
Original analysis of the supplied journal article, identified as PMC6358382.